TrialLeukemia2010

NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951.

E Clappier et al.PubMed ↗Publisher ↗

No numbers read from the abstract.